Status:
UNKNOWN
Summative Usability Study of CEREBO® - a Non Invasive Intracranial Hemorrhage Detector
Lead Sponsor:
Bioscan Research Pvt. Ltd.
Conditions:
Usability
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Traumatic brain injury is one of the most common reasons for visits to the Emergency Department. More than 90% of patients who have suffered from head trauma present with a mild traumatic brain injury...
Detailed Description
A prospective interventional study designed to assess the summative usability and rapidity of CEREBO® - a portable device to detect intracranial haemorrhage. 10 participants from a Primary Health Cent...
Eligibility Criteria
Inclusion
- Operators
- Medical health professionals \>18 years of age with a valid medical license to practice medicine belonging to one of the following categories and have given a written consent to participate in the study.
- MBBS
- Ayush
- Nurse
- Others
- Subjects
- Of all ages and gender, have understood the study and gave a written informed consent.
Exclusion
- Subjects
- Cognitively impaired subjects unable to understand the study procedure
Key Trial Info
Start Date :
April 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05340127
Start Date
April 20 2022
End Date
January 31 2023
Last Update
April 22 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.